ARTICLE

THE EFFICACY AND SAFETY OF CHLORHEXIDINE IN NOSOCOMIAL INFECTIONS

  1. HOME
  2. ARTICLE

03 Pages : 29-36

http://dx.doi.org/10.31703/gdddr.2021(VI-III).03      10.31703/gdddr.2021(VI-III).03      Published : Sep 2021

The Efficacy and Safety of Chlorhexidine in Nosocomial Infections

Abstract

    Chlorhexidine is a common skin antisepsis agent that is also found in toothpaste and mouthwash.When mixed with alcohol, it is a particularly efficient antibacterial. Because it forms a strong bond with aminoacid subunits in the peripheral skin and mucosal layers. Its antibacterial properties remain for a long time,enabling it to be an efficacious antiseptic agent. Chlorhexidine is applied on various medical devices which provide protection against various internal infections caused by catheter. Chlorhexidine-related contact dermatitis is uncommon among healthcare employees.in individuals where the incidence of allergic reactionsis very common, the rate of skin allergic reactions caused by chlorhexidine ranges from 3.5 to 6.5 percent.Chlorhexidine induced allergic reactions are frequently misdiagnosed, leading to under reporting.

    Chlorhexidine, Acute Hypersensitivity, Contact Dermatitis, Intravascular Access, Nosocomial Infections

    (1) Muhammad Zahoor
    PhD Scholar, Department of Pharmacy, Faculty of Biological Sciences, Quaid I Azam University, Islamabad, Pakistan
    (2) Syeda Komal Fatima
    Pharm D Graduate, Department of Pharmacy, Faculty of Biological Sciences, Quaid I Azam University, Islamabad, Pakistan.
    (3) Rashid Munir
    PhD Scholar, Department of Pharmacy, Faculty of Biological Sciences, Quaid I Azam University, Islamabad, Pakistan
    (4) Gul Shahnaz
    Chairperson, Department of Pharmacy, Faculty of Biological Sciences, Quaid I Azam University, Islamabad, Pakistan
Fulltext PDF

References

  • Brookes, Z. L., Bescos, R., Belfield, L. A., Ali, K., & Roberts, A. (2020). Current uses of chlorhexidine for management of oral disease: a narrative review. Journal of dentistry, 103, 103497.
  • Chaiyakunapruk, N., Veenstra, D. L., Lipsky, B. A., & Saint, S. (2002). Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta- analysis. Annals of internal medicine, 136(11), 792-801.
  • Chiewchalermsri, C., Sompornrattanaphan, M., Wongsa, C., & Thongngarm, T. (2020). Chlorhexidine allergy: current challenges and future prospects. Journal of asthma and allergy, 13, 127.
  • Elliott, T. (2000). Intravascular catheter-related sepsis-novel methods of prevention. Intensive Care Medicine, 26, S45.
  • Hibbard, J. S., Mulberry, G. K., & Brady, A. R. (2002). A clinical study comparing the skin antisepsis and safety of ChloraPrep, 70 Percent isopropyl alcohol, and 2 Percent aqueous chlorhexidine. Journal of Infusion Nursing, 25(4), 244-249.
  • Lim, K. S., & Kam, P. C. A. (2008). Chlorhexidine- pharmacology and clinical applications. Anaesthesia and intensive care, 36(4), 502-512.
  • Logghe, C., Van Ossel, C. H., D'Hoore, W., Ezzedine, H., Wauters, G., & Haxhe, J. J. (1997). Evaluation of chlorhexidine and silver- sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. Journal of Hospital Infection, 37(2), 145-156
  • Mermel, L. A. (2001). New technologies to prevent intravascular catheter-related bloodstream infections. Emerging infectious diseases, 7(2), 197.
  • Noor, S. S. S. E. (2016). Chlorhexidine: Its properties and effects. Research Journal of Pharmacy and Technology, 9(10), 1755-1760
  • Pereira, L. J., Lee, G. M., & Wade, K. J. (1997). An evaluation of five protocols for surgical handwashing in relation to skin condition and microbial counts. Journal of Hospital Infection, 36(1), 49-65.
  • Rose, M. A., Garcez, T., Savic, S., & Garvey, L. H. (2019). Chlorhexidine allergy in the perioperative setting: a narrative review. British journal of anaesthesia, 123(1), e95- e103.
  • Steinsapir, K. D., & Woodward, J. A. (2017). Chlorhexidine keratitis: safety of chlorhexidine as a facial antiseptic. Dermatologic Surgery, 43(1), 1-6.
  • Wand, M. E., Bock, L. J., Bonney, L. C., & Sutton, J. M. (2017). Mechanisms of increased resistance to chlorhexidine and cross- resistance to colistin following exposure of Klebsiella pneumoniae clinical isolates to chlorhexidine. Antimicrobial agents and chemotherapy, 61(1), e01162-16.
  • Wang, H., Agrawal, A., Wang, Y., Crawford, D. W., Siler, Z. D., Peterson, M. L., ... & Phillips, K. S. (2021). An ex vivo model of medical device- mediated bacterial skin translocation. Scientific reports, 11(1), 1-14.

Cite this article

APA

CHICAGO

    CHICAGO : Zahoor, Muhammad, Syeda Komal Fatima, and Rashid Munir. 2021. "The Efficacy and Safety of Chlorhexidine in Nosocomial Infections." Global Drug Design & Development Review, VI (III): 29-36 doi: 10.31703/gdddr.2021(VI-III).03

HARVARD

    HARVARD : ZAHOOR, M., FATIMA, S. K. & MUNIR, R. 2021. The Efficacy and Safety of Chlorhexidine in Nosocomial Infections. Global Drug Design & Development Review, VI, 29-36.

MHRA

    MHRA : Zahoor, Muhammad, Syeda Komal Fatima, and Rashid Munir. 2021. "The Efficacy and Safety of Chlorhexidine in Nosocomial Infections." Global Drug Design & Development Review, VI: 29-36

MLA

    MLA : Zahoor, Muhammad, Syeda Komal Fatima, and Rashid Munir. "The Efficacy and Safety of Chlorhexidine in Nosocomial Infections." Global Drug Design & Development Review, VI.III (2021): 29-36 Print.

OXFORD

    OXFORD : Zahoor, Muhammad, Fatima, Syeda Komal, and Munir, Rashid (2021), "The Efficacy and Safety of Chlorhexidine in Nosocomial Infections", Global Drug Design & Development Review, VI (III), 29-36

TURABIAN

    TURABIAN : Zahoor, Muhammad, Syeda Komal Fatima, and Rashid Munir. "The Efficacy and Safety of Chlorhexidine in Nosocomial Infections." Global Drug Design & Development Review VI, no. III (2021): 29-36. https://doi.org/10.31703/gdddr.2021(VI-III).03